SG3 Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,000
Closed -$289K 811
2022
Q1
$289K Buy
+4,000
New +$288K 0.01% 702
2021
Q4
Sell
-8,500
Closed -$1.02M 1279
2021
Q3
$1.08M Buy
8,500
+3,000
+55% +$437K 0.03% 449
2021
Q2
$915K Buy
5,500
+4,000
+267% +$648K 0.03% 498
2021
Q1
$273K Buy
+1,500
New +$348K 0.01% 901
2020
Q4
Sell
-500
Closed -$102K 1215
2020
Q3
$110K Buy
+500
New +$106K ﹤0.01% 785

Other funds holding TDOC

SG3 Management's TDOC Position: Q2 2022 in Review

SG3 Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,000 shares — an estimated $289K sold.

SG3 Management first reported a position in TDOC in Q3 2020 and held it in 5 quarters. The position peaked at $1.08M in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • SG3 Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 4,000 Teladoc Health shares in Q2 2022, an estimated $289K.
  • SG3 Management first reported a position in Teladoc Health in Q3 2020 and held it in 5 quarters.
  • SG3 Management's Teladoc Health position peaked at $1.08M in Q3 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.